Since the GCGR agonists have emerged as potential therapeutic options for managing obesity, diabetes and other metabolic disorders, one intriguing development in this field is the discovery of unimolecular dual agonists that simultaneously activate both the GLP1R and the GCGR. The gene discussed is GCGR; the disease is Obesity.